Novolog Pharm-Up 1966 Ltd

Price Chart

Risk-Adjusted Performance

Novolog Pharm-Up 1966 Ltd (NVLG) Price Performance

Novolog Pharm-Up 1966 Ltd (NVLG) trades on TA in ILS. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at ILS100.90, down 8.77% from the previous close.

Over the past year, NVLG has traded between a low of ILS100.90 and a high of ILS160.88. The stock has lost 37.0% over this period. It is currently 37.3% below its 52-week high.

Novolog Pharm-Up 1966 Ltd has a market capitalization of $584.95M, with a price-to-earnings ratio of 57.25 and a dividend yield of 0.03%.

About Novolog Pharm-Up 1966 Ltd

Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Health Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Health Services division provides personalized medicine, medical and diagnostic laboratory, and other medical services to patients, health organizations, insurance companies, multinational companies, and government bodies. The Digital division identifies and develops technological tools for health services; deals with making medical information accessible to the public through medical websites; promotes digital presence for clinics, doctors therapists, and medical bodies; provides services and management tools; and operates and markets digital platforms for doctors and clinics. In addition, it provides appointment scheduling, calendar management, and telemedicine meeting management. Novolog (Pharm-Up 1966) Ltd was incorporated in 1966 and is headquartered in Modi'in-Maccabim-Re'ut, Israel.